(Q81430222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Paola Caramaschi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Domenico Biasi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Elisabetta Tonolli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sara Pieropan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Antonio Carletto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Alessandro Volpe

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Lisa Maria Bambara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

23 February 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

58-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15726373%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-004-0571-9

8 January 2020

exact match

0 references

cites work

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

1 reference

12 December 2020

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

1 reference

12 December 2020

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

Citrullination of synovial proteins in murine models of rheumatoid arthritis

1 reference

12 December 2020

Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.

1 reference

12 December 2020

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

12 December 2020

Clinical utility of the anti-CCP assay in patients with rheumatic diseases

1 reference

12 December 2020

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

12 December 2020

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.

1 reference

12 December 2020

Review article: safety of infliximab in clinical trials

1 reference

12 December 2020

High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

1 reference

12 December 2020

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

1 reference

12 December 2020

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

12 December 2020

Etanercept-induced subacute cutaneous lupus erythematosus

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.

1 reference

12 December 2020

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

12 December 2020

Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab)

1 reference

12 December 2020

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies

1 reference

12 December 2020

Anti-TNF-alpha-induced systemic lupus syndrome

1 reference

12 December 2020

In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL

1 reference

12 December 2020

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus and TNF-alpha blockers

1 reference

12 December 2020

Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

12 December 2020

Infliximab-induced lupus in Crohn's disease: a case report.

1 reference

12 December 2020

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

1 reference

12 December 2020

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

12 December 2020

Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis

1 reference

12 December 2020

Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE).

1 reference

12 December 2020

A lupus-like syndrome associated with infliximab therapy

1 reference

12 December 2020